Retroperitoneal Fibrosis: Clinical Trials

2 trials for Retroperitoneal Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1
Phase 21Completed 1

Follow Retroperitoneal Fibrosis: new trials by email Literature Review of Retroperitoneal Fibrosis trials Research Report on Retroperitoneal Fibrosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
Sirolimus, Corticosteroid - Retroperitoneal Fibrosis
Phase 2 / Phase 3CompletedPeking University International Hospital642018-07-012026-09-22
Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Methotrexate+Prednisone, Prednisone - Idiopathic Retroperitoneal Fibrosis, Perianeurysmal Retroperitoneal Fibrosis
Phase 3UnknownUniversity of Parma2002007-05-012010-11-15

Broader conditions

Fibrosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Prednisone (2)  ·  Adrenal Cortex Hormones (1)  ·  Sirolimus (1)

Sponsors

Peking University International Hospital (1)  ·  University of Parma (1)

Countries

China (1)  ·  Italy (1)

Top investigators

Augusto Vaglio, MD, PhD (1)  ·  Hui Gao, Doctor (1)

Results publications

PMID 40974866

NIH funding

2008 (1)